When does Sanofi report earnings and how will SNW.DE stock react?

Sanofi reports Q4 on 29 Jan 2026 at about 16:30 UTC, at XETRA close; SNW.DE stock is likely to gap based on EPS versus expectations and guidance, with high intraday volume and volatility expected around the release.

What are the key numbers to watch in the SNW.DE earnings report?

Investors should watch EPS (trailing **€5.24**), revenue performance in Pharmaceuticals and Vaccines, operating margin near **18.65%**, and free cash flow commentary to gauge SNW.DE stock’s post-report direction.

What is Meyka AI’s view and forecast for SNW.DE stock?

Meyka AI forecasts a monthly target of **€82.48** (+6.73%) and a 12-month target of **€78.89** (+2.09%) versus **€77.28** today; Meyka AI rates SNW.DE **73.75 (B+), Suggestion: BUY**, noting forecasts are model-based and not guarantees.

How does valuation support an investment case for SNW.DE stock?

SNW.DE stock trades at a PE around **14.84** with a book value per share **€60.37** and dividend yield **5.06%**, which supports a value-income case if earnings remain stable and free cash flow recovers.

DE Stocks

SNW.DE Sanofi (XETRA) Q4 earnings 29 Jan 2026: EPS, guidance and market signal

ByHuzaifa Zahoor January 29, 2026

Sanofi (SNW.DE) trades at €77.28 on XETRA today intraday after a €2.46 (-3.09%) drop ahead of its Q4 earnings due 29 Jan 2026 near market close. SNW.DE stock faces focus on EPS €5.24 and the company’s guidance versus market expectations, with average volume at 12,621 shares and today’s volume already 30,831. Investors should watch profitability metrics, the dividend yield of 5.06%, and whether management tightens full-year guidance, as these items will drive price action after the report.